India Crosses 80 Lakh HPV Vaccinations: National HPV Vaccination Campaign Explained

Why is HPV Vaccination in News?

India has crossed the milestone of administering more than 80 lakh Human Papillomavirus vaccine doses under the National HPV Vaccination Campaign. The programme primarily targets eligible adolescent girls and represents an important public-health intervention aimed at reducing the future burden of cervical cancer and other diseases associated with HPV infection.

The campaign was launched nationally in 2026 and vaccination is being made available through government health facilities. The initiative is important not only from a health-policy perspective but also for competitive examinations because it connects immunisation, women's health, cancer prevention and India's expanding digital vaccination infrastructure.

What is Human Papillomavirus?

Human Papillomavirus, commonly known as HPV, refers to a large group of related viruses. Some HPV types can cause common skin or mucosal infections, while certain high-risk strains are strongly associated with cancers, particularly cervical cancer.

Persistent infection with high-risk HPV strains is one of the most important causes of cervical cancer. However, most HPV infections do not automatically lead to cancer. In many individuals the immune system clears the infection naturally. The major public-health concern is persistent infection with high-risk variants.

Why is Cervical Cancer Prevention Important?

Cervical cancer affects the cervix, which is the lower part of the uterus. It remains an important women's health challenge, particularly in countries where vaccination and regular screening coverage are incomplete.

Cervical cancer is considered unusually preventable compared with many other cancers because two major tools are available: vaccination against major cancer-causing HPV types and screening for precancerous changes. Early detection and appropriate treatment of abnormal cervical changes can prevent progression to invasive cancer.

National HPV Vaccination Campaign

India's National HPV Vaccination Campaign was launched on 28 February 2026 in Ajmer, Rajasthan. The programme provides vaccination through government healthcare facilities. Eligible beneficiaries can receive vaccination without charge under the public programme, subject to the campaign's eligibility and consent requirements.

Government facilities involved in primary healthcare, including Ayushman Arogya Mandirs and other public-health institutions, form an important part of the vaccination network.

Gardasil-4 Vaccine

The campaign uses the quadrivalent HPV vaccine Gardasil-4. A quadrivalent vaccine targets four HPV types. Students should remember that the word quadrivalent generally refers to protection directed against four targeted variants or antigens.

Vaccines train the immune system to recognise specific disease-causing agents or components associated with them. HPV vaccination works best as a preventive intervention when administered before substantial exposure to the virus.

Role of U-WIN

Registration and digital tracking of beneficiaries are supported through U-WIN, India's digital vaccination platform. U-WIN extends the use of digital tools in immunisation by supporting registration, vaccination records and tracking of beneficiaries.

This reflects a wider transition towards digital public-health infrastructure, where vaccination programmes can increasingly use electronic records to improve continuity, monitoring and coverage.

Safety Monitoring

Large immunisation programmes require systems to monitor adverse events following immunisation, commonly abbreviated as AEFI. An AEFI is any untoward medical occurrence that happens after vaccination and does not automatically mean that the vaccine caused the event.

Medical assessment is required to determine whether there is a causal relationship. Surveillance systems are therefore essential for identifying genuine safety signals while also distinguishing unrelated medical events that happen after vaccination by coincidence.

Public Health Significance

The HPV programme has long-term implications because cancer prevention benefits are expected to emerge over years. Higher vaccine coverage among eligible age groups can reduce circulation of vaccine-targeted HPV types and lower the risk of precancerous cervical lesions and cervical cancer.

Vaccination does not eliminate the importance of cervical cancer screening. Screening remains necessary because vaccines do not necessarily cover every cancer-causing HPV type and because many adults may not have received vaccination at the recommended age.

Important Facts for Exams

• HPV stands for Human Papillomavirus.
• Persistent infection with certain high-risk HPV types is strongly associated with cervical cancer.
• The cervix is the lower portion of the uterus.
• Gardasil-4 is a quadrivalent HPV vaccine.
• U-WIN is associated with digital immunisation services in India.
• Ayushman Arogya Mandirs form part of India's strengthened primary healthcare network.
• AEFI stands for Adverse Event Following Immunisation.
• Vaccination and screening are both important components of cervical cancer prevention.